Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 25 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2017 Filed Mar 7, 2017 17:20 UTC |
NICOLS JOHN JDirector · President and CEO
|
Tax withholdingCommon Stock | 149,119 | $4.15 | $618,843.85 |
DisclosureSEC source: 0001140361-17-010917 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164,854 F1 · kind: Shares withheld by the Issuer on vesting of performance stock units solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the release of shares of stock acquired by the Reporting Person pursuant to the prior achievement of performance metrics as determined by the Issuer's compensation committee. Read SEC document |
| March 05, 2017 Filed Mar 7, 2017 22:19 UTC |
Lalonde JamesSVP, R&D
|
Tax withholdingCommon Stock | 20,630 | $4.15 | $85,614.50 |
DisclosureSEC source: 0001140361-17-010913 · doc1.xml · nonDerivative · entry 1 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,986 F1 · kind: Shares withheld by the Issuer on vesting of performance stock units solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the release of shares of stock acquired by the Reporting Person pursuant to the prior achievement of performance metrics as determined by the Issuer's compensation committee. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 18:45 UTC |
NICOLS JOHN JDirector · President and CEO
|
Tax withholdingCommon Stock | 8,554 | $4.35 | $37,209.90 |
DisclosureSEC source: 0001140361-17-007513 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,313,973 F1 · kind: Shares withheld by the Issuer on vesting of restricted stock units ("RSUs") solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the release of the RSUs upon the vesting thereof. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 23:44 UTC |
Lalonde JamesSVP, R&D
|
Tax withholdingCommon Stock | 2,404 | $4.35 | $10,457.40 |
DisclosureSEC source: 0001140361-17-007512 · doc1.xml · nonDerivative · entry 1 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,616 F1 · kind: Shares withheld by the Issuer on vesting of restricted stock units ("RSUs") solely to cover applicable withholding taxes. No shares were sold in the open market; the transaction reported herein was executed automatically upon the release of the RSUs upon the vesting thereof. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 20:26 UTC |
Aldridge Michael D.See Remarks
|
GrantStock Options (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001140361-17-004967 · doc1.xml · derivative · entry 1 Aldridge Michael D. · CIK 0001687664 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-02-03 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 3, 2018, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 3, 2021. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 20:25 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
GrantStock Options (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001140361-17-004966 · doc1.xml · derivative · entry 1 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2027-02-03 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 3, 2018, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 3, 2021. Read SEC document |
| February 03, 2017 Filed Feb 7, 2017 20:24 UTC |
NICOLS JOHN JDirector · President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001140361-17-004965 · doc1.xml · derivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2027-02-03 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 3, 2018, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 3, 2021. Read SEC document |
| February 03, 2017 Filed Feb 8, 2017 01:27 UTC |
Lalonde JamesSVP, R&D
|
GrantStock Options (Right to Buy) · Derivative | 110,000 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001140361-17-004968 · doc1.xml · derivative · entry 1 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2027-02-03 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject thereto on February 3, 2018, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 3, 2021. Read SEC document |
| January 16, 2017 Filed Feb 14, 2017 18:42 UTC |
SANGSTER GORDONSVP & Chief Financial Officer
|
GrantCommon Stock | 105,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-007509 · doc1.xml · nonDerivative · entry 1 SANGSTER GORDON · CIK 0001243383 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,533 F1 · kind: Represents shares of common stock issuable pursuant to performance stock units for which achievement has been certified by the Issuer's compensation committee. Shares will be issued in two equal installments on each of March 5, 2017 and March 5, 2018, subject to continued employment through such date. Read SEC document |
| January 16, 2017 Filed Feb 14, 2017 18:44 UTC |
NICOLS JOHN JDirector · President and CEO
|
GrantCommon Stock | 421,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-007511 · doc1.xml · nonDerivative · entry 1 NICOLS JOHN J · CIK 0001238884 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322,527 F1 · kind: Represents shares of common stock issuable pursuant to performance stock units for which achievement has been certified by the Issuer's compensation committee. Shares will be issued in two equal installments on each of March 5, 2017 and March 5, 2018, subject to continued employment through such date. Read SEC document |
| January 16, 2017 Filed Feb 14, 2017 23:43 UTC |
Lalonde JamesSVP, R&D
|
GrantCommon Stock | 66,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-007510 · doc1.xml · nonDerivative · entry 1 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,020 F1 · kind: Represents shares of common stock issuable pursuant to performance stock units for which achievement has been certified by the Issuer's compensation committee. Shares will be issued in two equal installments on each of March 5, 2017 and March 5, 2018, subject to continued employment through such date. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 22:53 UTC |
Lalonde JamesSVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,666 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0001140361-17-001259 · doc1.xml · derivative · entry 2 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,666 shares Expires 2017-01-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| January 05, 2017 Filed Jan 9, 2017 22:53 UTC |
Lalonde JamesSVP, R&D
|
Exercise / conversionCommon Stock | 6,666 | $2.45 | $16,331.70 |
DisclosureSEC source: 0001140361-17-001259 · doc1.xml · nonDerivative · entry 1 Lalonde James · CIK 0001599677 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2016 Filed Nov 16, 2016 00:24 UTC |
Yang Patrick YDirector
|
PurchaseCommon Stock | 10,000 | $4.83 | $48,300.00 |
DisclosureSEC source: 0001140361-16-086863 · doc1.xml · nonDerivative · entry 1 Yang Patrick Y · CIK 0001309988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,340 F1 · price: This transaction was executed in multiple trades in prices ranging from $4.775 to $4.85, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote. Read SEC document |
| October 16, 2016 Filed Oct 18, 2016 19:45 UTC |
Aldridge Michael D.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $4.37 | $0.00 |
DisclosureSEC source: 0001140361-16-083020 · doc1.xml · derivative · entry 1 Aldridge Michael D. · CIK 0001687664 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2026-10-15 F1 · derivative.exercise_date: Option vests and becomes exercisable with respect to 25% of the shares subject thereto on October 16, 2017, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on October 16, 2020 contingent upon the continued employment of the Reporting Person through each such vesting date. Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 22:27 UTC |
VIVO VENTURES VII, LLC10% owner
Vivo Ventures Fund VII, L.P.10% owner
|
SaleCommon Stock | 2,381 | $4.25 | $10,126.15 |
DisclosureSEC source: 0001225208-16-039231 · doc4.xml · nonDerivative · entry 2 VIVO VENTURES VII, LLC · CIK 0001565020 · 10% owner Vivo Ventures Fund VII, L.P. · CIK 0001509160 · 10% owner Vivo Ventures VII Affiliates Fund, L.P. · CIK 0001538309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Ventures VII Affiliates Fund, L.P. Disclosed balance after: 112,940 F1 · price: The price shown is a weighted average sales price. The shares were sold at prices ranging from $4.10 to $4.40 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · ownership.nature: These shares are owned directly by Vivo Ventures Affliates Fund VII, L.P. Vivo Ventures VII, LLC is its general partner, and as such may be deemed to beneficially own these shares. Read SEC document |
| September 08, 2016 Filed Sep 12, 2016 22:27 UTC |
VIVO VENTURES VII, LLC10% owner
Vivo Ventures Fund VII, L.P.10% owner
|
SaleCommon Stock | 109,219 | $4.25 | $464,497.49 |
DisclosureSEC source: 0001225208-16-039231 · doc4.xml · nonDerivative · entry 1 VIVO VENTURES VII, LLC · CIK 0001565020 · 10% owner Vivo Ventures Fund VII, L.P. · CIK 0001509160 · 10% owner Vivo Ventures VII Affiliates Fund, L.P. · CIK 0001538309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Vivo Ventures Fund VII, L.P. Disclosed balance after: 5,181,885 F1 · price: The price shown is a weighted average sales price. The shares were sold at prices ranging from $4.10 to $4.40 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F2 · ownership.nature: These shares are owned directly by Vivo Ventures Fund VII, L.P. Vivo Ventures VII, LLC is its general partner, and as such may be deemed to beneficially own these shares. Read SEC document |
| August 21, 2015 Filed Dec 8, 2017 02:22 UTC |
Yang Patrick YDirector
|
PurchaseCommon Stock | 10,000 | $3.98 | $39,769.00 |
DisclosureSEC source: 0001140361-17-045397 · doc1.xml · nonDerivative · entry 1 Yang Patrick Y · CIK 0001309988 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,234 F1 · price: This transaction was executed in multiple trades in prices ranging from $3.94 to $3.99, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.